Matthew Frohn

Oxford Technology Management Ltd. (Oxford Technology) a venture capital firm founded by Mr. Lucius Cary in 1972. The firm is headquartered in Oxford, UK.

Longwall Venture Partners LLP (Longwall Ventures) is a venture capital firm founded in 2006. The firm is headquartered in Oxford, the United Kingdom.

OrganOx Ltd. develops a medical device for liver transplantation. The firm's product OrganOx metra, is a fully automated normothermic liver perfusion device for improved organ preservation. It also engages in research and development of transplantation related technologies. The company was founded by Peter Friend and Constantin Coussios in April 2008 and is headquartered in Oxford, the United Kingdom.

OrganOx Ltd. develops a medical device for liver transplantation. The firm's product OrganOx metra, is a fully automated normothermic liver perfusion device for improved organ preservation. It also engages in research and development of transplantation related technologies. The company was founded by Peter Friend and Constantin Coussios in April 2008 and is headquartered in Oxford, the United Kingdom.

OxSonics Ltd. provides treatments to solid tumour cancer patients. Its drug delivery platform, SonoTran, delivers drugs throughout tumour volumes including to those areas that lie farthest from blood vessels. The company also provides on-screen feedback as to where and when drug delivery has taken place, maximizing the potential of complete tumour coverage. OxSonics was founded by Colin Story, Constantin Coussios, Robert Carlisle and Christian Coviello in July 2013 and is headquartered in Oxford, the United Kingdom.

Caristo Diagnostics Ltd. engages in the development of cardiovascular diagnostic tools. The company was founded by Charalambos Antoniades on June 22, 2018 and is headquartered in Oxford, the United Kingdom.

Scancell Ltd. researches and develops techniques for isolating foetal cells from a maternal blood sample. The company was founded by Lindy Durrant in 1997 and is headquartered in Nottingham, the United Kingdom.

Oxford Technology Management Ltd. (Oxford Technology) a venture capital firm founded by Mr. Lucius Cary in 1972. The firm is headquartered in Oxford, UK.

Oxis Energy Ltd. manufactures sulphur polymer rechargeable batteries. It develops technology around sulfur based cathode materials, highly stable electrolyte systems and anode made of lithium metal and intercalation materials. The firm offers stable cathode and electrolyte systems which are optimized for performance with different anodes including lithium-metal. Its products include: cell components, standard pouch cell, customized cell and batteries. The company was founded by Ken Pelton, Justin Gaisford Martin, Andrea Giacomo Mica and Gleb Ivanov in 2004 and is headquartered in Abingdon, the United Kingdom.

OxSonics Ltd. provides treatments to solid tumour cancer patients. Its drug delivery platform, SonoTran, delivers drugs throughout tumour volumes including to those areas that lie farthest from blood vessels. The company also provides on-screen feedback as to where and when drug delivery has taken place, maximizing the potential of complete tumour coverage. OxSonics was founded by Colin Story, Constantin Coussios, Robert Carlisle and Christian Coviello in July 2013 and is headquartered in Oxford, the United Kingdom.

Longwall Venture Partners LLP (Longwall Ventures) is a venture capital firm founded in 2006. The firm is headquartered in Oxford, the United Kingdom.

OrganOx Ltd. develops a medical device for liver transplantation. The firm's product OrganOx metra, is a fully automated normothermic liver perfusion device for improved organ preservation. It also engages in research and development of transplantation related technologies. The company was founded by Peter Friend and Constantin Coussios in April 2008 and is headquartered in Oxford, the United Kingdom.

OrganOx Ltd. develops a medical device for liver transplantation. The firm's product OrganOx metra, is a fully automated normothermic liver perfusion device for improved organ preservation. It also engages in research and development of transplantation related technologies. The company was founded by Peter Friend and Constantin Coussios in April 2008 and is headquartered in Oxford, the United Kingdom.

Caristo Diagnostics Ltd. engages in the development of cardiovascular diagnostic tools. The company was founded by Charalambos Antoniades on June 22, 2018 and is headquartered in Oxford, the United Kingdom.

Caristo Diagnostics Ltd. engages in the development of cardiovascular diagnostic tools. The company was founded by Charalambos Antoniades on June 22, 2018 and is headquartered in Oxford, the United Kingdom.

OrganOx Ltd. develops a medical device for liver transplantation. The firm's product OrganOx metra, is a fully automated normothermic liver perfusion device for improved organ preservation. It also engages in research and development of transplantation related technologies. The company was founded by Peter Friend and Constantin Coussios in April 2008 and is headquartered in Oxford, the United Kingdom.

Oxford Cancer Biomarkers Ltd. provides cancer treatment services. It offers a suite of drug-specific companion diagnostic kits that allow the biomarker to be directly measured in tumor biopsies or patient DNA and thereby patients that respond favorably to the drug identified. The company was founded by David Kerr and Nick LaThangue in 2012 and is headquartered in Oxford, the United Kingdom.

Caristo Diagnostics Ltd. engages in the development of cardiovascular diagnostic tools. The company was founded by Charalambos Antoniades on June 22, 2018 and is headquartered in Oxford, the United Kingdom.

OxSonics Ltd. provides treatments to solid tumour cancer patients. Its drug delivery platform, SonoTran, delivers drugs throughout tumour volumes including to those areas that lie farthest from blood vessels. The company also provides on-screen feedback as to where and when drug delivery has taken place, maximizing the potential of complete tumour coverage. OxSonics was founded by Colin Story, Constantin Coussios, Robert Carlisle and Christian Coviello in July 2013 and is headquartered in Oxford, the United Kingdom.

OrganOx Ltd. develops a medical device for liver transplantation. The firm's product OrganOx metra, is a fully automated normothermic liver perfusion device for improved organ preservation. It also engages in research and development of transplantation related technologies. The company was founded by Peter Friend and Constantin Coussios in April 2008 and is headquartered in Oxford, the United Kingdom.

Longwall Venture Partners LLP (Longwall Ventures) is a venture capital firm founded in 2006. The firm is headquartered in Oxford, the United Kingdom.

Scancell Ltd. researches and develops techniques for isolating foetal cells from a maternal blood sample. The company was founded by Lindy Durrant in 1997 and is headquartered in Nottingham, the United Kingdom.

OrganOx Ltd. develops a medical device for liver transplantation. The firm's product OrganOx metra, is a fully automated normothermic liver perfusion device for improved organ preservation. It also engages in research and development of transplantation related technologies. The company was founded by Peter Friend and Constantin Coussios in April 2008 and is headquartered in Oxford, the United Kingdom.

OxSonics Ltd. provides treatments to solid tumour cancer patients. Its drug delivery platform, SonoTran, delivers drugs throughout tumour volumes including to those areas that lie farthest from blood vessels. The company also provides on-screen feedback as to where and when drug delivery has taken place, maximizing the potential of complete tumour coverage. OxSonics was founded by Colin Story, Constantin Coussios, Robert Carlisle and Christian Coviello in July 2013 and is headquartered in Oxford, the United Kingdom.

Caristo Diagnostics Ltd. engages in the development of cardiovascular diagnostic tools. The company was founded by Charalambos Antoniades on June 22, 2018 and is headquartered in Oxford, the United Kingdom.

OxSonics Ltd. provides treatments to solid tumour cancer patients. Its drug delivery platform, SonoTran, delivers drugs throughout tumour volumes including to those areas that lie farthest from blood vessels. The company also provides on-screen feedback as to where and when drug delivery has taken place, maximizing the potential of complete tumour coverage. OxSonics was founded by Colin Story, Constantin Coussios, Robert Carlisle and Christian Coviello in July 2013 and is headquartered in Oxford, the United Kingdom.

Oxford Cancer Biomarkers Ltd. provides cancer treatment services. It offers a suite of drug-specific companion diagnostic kits that allow the biomarker to be directly measured in tumor biopsies or patient DNA and thereby patients that respond favorably to the drug identified. The company was founded by David Kerr and Nick LaThangue in 2012 and is headquartered in Oxford, the United Kingdom.

Oxis Energy Ltd. manufactures sulphur polymer rechargeable batteries. It develops technology around sulfur based cathode materials, highly stable electrolyte systems and anode made of lithium metal and intercalation materials. The firm offers stable cathode and electrolyte systems which are optimized for performance with different anodes including lithium-metal. Its products include: cell components, standard pouch cell, customized cell and batteries. The company was founded by Ken Pelton, Justin Gaisford Martin, Andrea Giacomo Mica and Gleb Ivanov in 2004 and is headquartered in Abingdon, the United Kingdom.

Oxis Energy Ltd. manufactures sulphur polymer rechargeable batteries. It develops technology around sulfur based cathode materials, highly stable electrolyte systems and anode made of lithium metal and intercalation materials. The firm offers stable cathode and electrolyte systems which are optimized for performance with different anodes including lithium-metal. Its products include: cell components, standard pouch cell, customized cell and batteries. The company was founded by Ken Pelton, Justin Gaisford Martin, Andrea Giacomo Mica and Gleb Ivanov in 2004 and is headquartered in Abingdon, the United Kingdom.

Oxis Energy Ltd. manufactures sulphur polymer rechargeable batteries. It develops technology around sulfur based cathode materials, highly stable electrolyte systems and anode made of lithium metal and intercalation materials. The firm offers stable cathode and electrolyte systems which are optimized for performance with different anodes including lithium-metal. Its products include: cell components, standard pouch cell, customized cell and batteries. The company was founded by Ken Pelton, Justin Gaisford Martin, Andrea Giacomo Mica and Gleb Ivanov in 2004 and is headquartered in Abingdon, the United Kingdom.

OrganOx Ltd. develops a medical device for liver transplantation. The firm's product OrganOx metra, is a fully automated normothermic liver perfusion device for improved organ preservation. It also engages in research and development of transplantation related technologies. The company was founded by Peter Friend and Constantin Coussios in April 2008 and is headquartered in Oxford, the United Kingdom.

OrganOx Ltd. develops a medical device for liver transplantation. The firm's product OrganOx metra, is a fully automated normothermic liver perfusion device for improved organ preservation. It also engages in research and development of transplantation related technologies. The company was founded by Peter Friend and Constantin Coussios in April 2008 and is headquartered in Oxford, the United Kingdom.

OrganOx Ltd. develops a medical device for liver transplantation. The firm's product OrganOx metra, is a fully automated normothermic liver perfusion device for improved organ preservation. It also engages in research and development of transplantation related technologies. The company was founded by Peter Friend and Constantin Coussios in April 2008 and is headquartered in Oxford, the United Kingdom.

Oxis Energy Ltd. manufactures sulphur polymer rechargeable batteries. It develops technology around sulfur based cathode materials, highly stable electrolyte systems and anode made of lithium metal and intercalation materials. The firm offers stable cathode and electrolyte systems which are optimized for performance with different anodes including lithium-metal. Its products include: cell components, standard pouch cell, customized cell and batteries. The company was founded by Ken Pelton, Justin Gaisford Martin, Andrea Giacomo Mica and Gleb Ivanov in 2004 and is headquartered in Abingdon, the United Kingdom.

Longwall Venture Partners LLP (Longwall Ventures) is a venture capital firm founded in 2006. The firm is headquartered in Oxford, the United Kingdom.

OxSonics Ltd. provides treatments to solid tumour cancer patients. Its drug delivery platform, SonoTran, delivers drugs throughout tumour volumes including to those areas that lie farthest from blood vessels. The company also provides on-screen feedback as to where and when drug delivery has taken place, maximizing the potential of complete tumour coverage. OxSonics was founded by Colin Story, Constantin Coussios, Robert Carlisle and Christian Coviello in July 2013 and is headquartered in Oxford, the United Kingdom.

Oxford Cancer Biomarkers Ltd. provides cancer treatment services. It offers a suite of drug-specific companion diagnostic kits that allow the biomarker to be directly measured in tumor biopsies or patient DNA and thereby patients that respond favorably to the drug identified. The company was founded by David Kerr and Nick LaThangue in 2012 and is headquartered in Oxford, the United Kingdom.

Scancell Ltd. researches and develops techniques for isolating foetal cells from a maternal blood sample. The company was founded by Lindy Durrant in 1997 and is headquartered in Nottingham, the United Kingdom.

Oxford Technology Management Ltd. (Oxford Technology) a venture capital firm founded by Mr. Lucius Cary in 1972. The firm is headquartered in Oxford, UK.

Oxford Technology Management Ltd. (Oxford Technology) a venture capital firm founded by Mr. Lucius Cary in 1972. The firm is headquartered in Oxford, UK.

Scancell Ltd. researches and develops techniques for isolating foetal cells from a maternal blood sample. The company was founded by Lindy Durrant in 1997 and is headquartered in Nottingham, the United Kingdom.

Oxford Cancer Biomarkers Ltd. provides cancer treatment services. It offers a suite of drug-specific companion diagnostic kits that allow the biomarker to be directly measured in tumor biopsies or patient DNA and thereby patients that respond favorably to the drug identified. The company was founded by David Kerr and Nick LaThangue in 2012 and is headquartered in Oxford, the United Kingdom.